Changes of plasma vasoactive intestinal peptide and glucagon levels in congestive heart failure / 实用儿科临床杂志

ABSTRACT

Objective To investigate the changes of plasma vasoactive intestinal peptide (VIP) and glucagon (Glu) in congestive heart failure and its clinical significance. Methods The levels of plasma VIP and Glu were measured with radioimmunoassay in 40 patients with congestive heart failure, including 15 patients with cardiac function in degree Ⅰ, 25 cases with cardiac function in degree ⅡⅣ, and 23 normal children who were served as controls. Results The levels of plasma VIP and Glu increased than that in normal control group[(43.22?5 48) ng/L vs(32.24?4.46) ng/L, P